Cannabis Global, Inc.

Equities

CBGL

US13767G1004

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 15:58:15 2024-05-10 EDT			5-day change	1st Jan Change
0.0001 ^USD	0.00%		0.00%	-50.00%

2023	Cannabis Global, Inc. and KRTL International Corp. Enters into an Exclusive Distribution Agreement	CI
2022	Cannabis Global, Inc. Announces the Completion of Research and Development Testing for Infused Drink Straws	CI

Cannabis Global, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021

January 18, 2022 at 06:26 am

Cannabis Global, Inc. reported earnings results for the first quarter ended November 30, 2021. For the first quarter, the company reported revenue was USD 0.569562 million compared to USD 0.00453 million a year ago. Net income was USD 0.379705 million compared to net loss of USD 0.353224 million a year ago.

Latest news about Cannabis Global, Inc.

Cannabis Global, Inc. and KRTL International Corp. Enters into an Exclusive Distribution Agreement	23-05-02	CI
Cannabis Global, Inc. Announces the Completion of Research and Development Testing for Infused Drink Straws	22-12-07	CI
KRTL International Corp. and Cannabis Global Inc. Form Global Strategic Alliance	22-10-06	CI
Cannabis Global, Inc. Announces Executive Changes	22-07-26	CI
Cannabis Global, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2022	22-07-20	CI
Cannabis Global, Inc. Enters into Agreement with Lemon Glow Company, Inc	22-05-04	CI
Cannabis Global, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2022	22-04-19	CI
Cannabis Global, Inc. entered into an agreement to acquire Caliwanna Cannabis Brands from Caliwanna Distribution.	22-03-13	CI
Cannabis Global, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021	22-01-18	CI
Active Health Foods Inc., Cannabis Global and The Hub Craft, LLC Enter Non-Binding Letter of Intent to Develop California Cannabis MSO	22-01-04	CI
Cannabis Global, Inc. Reports Earnings Results for the Full Year Ended August 31, 2021	21-12-14	CI
Cannabis Global, Inc. Auditor Raises 'Going Concern' Doubt	21-12-13	CI
Cannabis Global, Inc. Announces Resignation of Melissa Riddell from Director	21-09-15	CI
Cannabis Global, Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2021	21-07-12	CI
CA- Cannabis Global, Inc Provides Revenue Guidance for the Fiscal Quarter Ended May 31, 2021	21-07-08	CI
Cannabis Global, Inc. Announces Resignation of Jim Riley as Director	21-06-15	CI
Cannabis Global, Inc. and Marijuana Company of America, Inc. Agrees to Operate A Joint Venture Through New Nevada Corporation Named Mcoa Lynwood Services, Inc	21-05-18	CI
Cannabis Global, Inc. Reports Earnings Results for the Second Quarter Ended February 28, 2021	21-04-19	CI
Cannabis Global, Inc. acquired an additional 18.8% stake in Natural Plant Extract of California, Inc. from Alan Tsai $0.33 million.	21-02-21	CI
Cannabis Global, Inc. completed the acquisition of 18.8% stake in Natural Plant Extract of California, Inc. from Edward Manolas for $1.7 million.	21-01-28	CI
HempSMART Ltd. cancelled the acquisition of ultra-clean label CBD beverage products from MCTC Holdings, Inc..	21-01-16	CI
Cannabis Global, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2020	21-01-13	CI
Cannabis Global, Inc. acquired Ethos Technology LLC for $0.36 million.	20-11-17	CI
Cannabis Global, Inc. Appoints Jim Riley as Independent Director	20-11-03	CI
Cannabis Global, Inc. Reports Earnings Results for the Full Year Ended August 31, 2020	20-10-27	CI

Chart Cannabis Global, Inc.

Duration

Period

More charts

Company Profile

Cannabis Global, Inc. manufactures and distributes various cannabis products through its ownership of Natural Plant Extract, Inc. The Company is engaged in developing the Ethos Comply Bag and conducts research and development in the areas of hemp, cannabis, and consumer food goods. It operates and manages Natural Plant Extract of California, Inc. (NPE) which holds two active California cannabis licenses: a Type 7 manufacturing license and a distribution license. These licenses allow NPE to distribute cannabis products in the State of California. These products included several types of cannabis products, including Cannabis flower packaged in various weights, which are sold to California licensed cannabis retailers and distributors; cannabis pre-rolls, which are sold to California licensed cannabis retailers and distributors, and cannabis edible products, which are sold to California licensed cannabis retailers and distributors.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
CANNABIS GLOBAL, INC.	-50.00%	411K
MODERNA, INC.	+17.96%	44.96B
IQVIA HOLDINGS INC.	+1.17%	42.65B
LONZA GROUP AG	+48.77%	41.85B
CELLTRION, INC.	-4.27%	29.04B
ICON PUBLIC LIMITED COMPANY	+11.42%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-21.39%	19.03B
BIO-TECHNE CORPORATION	+4.86%	12.75B
MEDPACE HOLDINGS, INC.	+27.29%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.50%	11.75B

Other Biotechnology & Medical Research